BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 24285678)

  • 1. Predictors of decreasing glomerular filtration rate and prevalence of chronic kidney disease after treatment of primary aldosteronism: renal outcome of 213 cases.
    Iwakura Y; Morimoto R; Kudo M; Ono Y; Takase K; Seiji K; Arai Y; Nakamura Y; Sasano H; Ito S; Satoh F
    J Clin Endocrinol Metab; 2014 May; 99(5):1593-8. PubMed ID: 24285678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association Between Acute Fall in Estimated Glomerular Filtration Rate After Treatment for Primary Aldosteronism and Long-Term Decline in Renal Function.
    Kobayashi H; Abe M; Nakamura Y; Takahashi K; Fujita M; Takeda Y; Yoneda T; Kurihara I; Itoh H; Tsuiki M; Wada N; Ichijo T; Katabami T; Ogawa Y; Kawashima J; Yoshimoto T; Sone M; Inagaki N; Watanabe M; Kamemura K; Matsuda Y; Izawa S; Tanabe M; Tanabe A; Suzuki T; Naruse M;
    Hypertension; 2019 Sep; 74(3):630-638. PubMed ID: 31327258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preoperative masked renal damage in Japanese patients with primary aldosteronism: identification of predictors for chronic kidney disease manifested after adrenalectomy.
    Utsumi T; Kawamura K; Imamoto T; Nagano H; Tanaka T; Kamiya N; Nihei N; Naya Y; Suzuki H; Ichikawa T
    Int J Urol; 2013 Jul; 20(7):685-91. PubMed ID: 23190329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic kidney disease score for predicting postoperative masked renal insufficiency in patients with primary aldosteronism.
    Tanase-Nakao K; Naruse M; Nanba K; Tsuiki M; Tagami T; Usui T; Okuno H; Shimatsu A; Hashimoto S; Katabami T; Ogo A; Okumura A; Umakoshi H; Suzuki T
    Clin Endocrinol (Oxf); 2014 Nov; 81(5):665-70. PubMed ID: 24821606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term effects of primary aldosteronism treatment on patients with primary aldosteronism and chronic kidney disease.
    Nakano Y; Murakami M; Hara K; Fukuda T; Horino M; Takeuchi A; Niitsu Y; Shiba K; Tsujimoto K; Komiya C; Yokoyama M; Ikeda K; Yoshimoto T; Fujii Y; Yamada T
    Clin Endocrinol (Oxf); 2023 Mar; 98(3):323-331. PubMed ID: 36367014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes analysis of surgical and medical treatments for patients with primary aldosteronism.
    Park KS; Kim JH; Yang YS; Hong AR; Lee DH; Moon MK; Choi SH; Shin CS; Kim SW; Kim SY
    Endocr J; 2017 Jun; 64(6):623-632. PubMed ID: 28458337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Change in kidney function after unilateral adrenalectomy in patients with primary aldosteronism: identification of risk factors for decreased kidney function.
    Kim IY; Park IS; Kim MJ; Han M; Rhee H; Seong EY; Lee DW; Lee SB; Kwak IS; Song SH; Chung HC
    Int Urol Nephrol; 2018 Oct; 50(10):1887-1895. PubMed ID: 29779118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Chronic kidney disease after adrenalectomy in a patient with primary aldosteronism].
    An WC; Yan HX; Deng ZZ; Chen F; Ou XH; Jin HX; Huang W
    Beijing Da Xue Xue Bao Yi Xue Ban; 2021 Dec; 53(6):1201-1204. PubMed ID: 34916706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Eplerenone on the Glomerular Filtration Rate (GFR) in Primary Aldosteronism: Sequential Changes in the GFR During Preoperative Eplerenone Treatment to Subsequent Adrenalectomy.
    Nakano Y; Yoshimoto T; Fukuda T; Murakami M; Bouchi R; Minami I; Hashimoto K; Fujii Y; Kihara K; Ogawa Y
    Intern Med; 2018 Sep; 57(17):2459-2466. PubMed ID: 29709927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal Outcomes in Medically and Surgically Treated Primary Aldosteronism.
    Hundemer GL; Curhan GC; Yozamp N; Wang M; Vaidya A
    Hypertension; 2018 Sep; 72(3):658-666. PubMed ID: 29987110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term renal outcomes in patients with primary aldosteronism.
    Sechi LA; Novello M; Lapenna R; Baroselli S; Nadalini E; Colussi GL; Catena C
    JAMA; 2006 Jun; 295(22):2638-45. PubMed ID: 16772627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Worsening of lipid metabolism after successful treatment of primary aldosteronism.
    Adolf C; Asbach E; Dietz AS; Lang K; Hahner S; Quinkler M; Rump LC; Bidlingmaier M; Treitl M; Ladurner R; Beuschlein F; Reincke M
    Endocrine; 2016 Oct; 54(1):198-205. PubMed ID: 27179655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolonged zona glomerulosa insufficiency causing hyperkalemia in primary aldosteronism after adrenalectomy.
    Fischer E; Hanslik G; Pallauf A; Degenhart C; Linsenmaier U; Beuschlein F; Bidlingmaier M; Mussack T; Ladurner R; Hallfeldt K; Quinkler M; Reincke M
    J Clin Endocrinol Metab; 2012 Nov; 97(11):3965-73. PubMed ID: 22893716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kidney impairment in primary aldosteronism.
    Wu VC; Yang SY; Lin JW; Cheng BW; Kuo CC; Tsai CT; Chu TS; Huang KH; Wang SM; Lin YH; Chiang CK; Chang HW; Lin CY; Lin LY; Chiu JS; Hu FC; Chueh SC; Ho YL; Liu KL; Lin SL; Yen RF; Wu KD;
    Clin Chim Acta; 2011 Jul; 412(15-16):1319-25. PubMed ID: 21345337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of eplerenone or spironolactone treatment in preserving renal function in primary aldosteronism.
    Fourkiotis V; Vonend O; Diederich S; Fischer E; Lang K; Endres S; Beuschlein F; Willenberg HS; Rump LC; Allolio B; Reincke M; Quinkler M;
    Eur J Endocrinol; 2013 Jan; 168(1):75-81. PubMed ID: 23033260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for renal impairment revealed after unilateral adrenalectomy in patients with primary aldosteronism.
    Kim DH; Kwon HJ; Ji SA; Jang HR; Jung SH; Kim JH; Kim JH; Lee JE; Huh W; Kim YG; Kim DJ; Oh HY
    Medicine (Baltimore); 2016 Jul; 95(27):e3930. PubMed ID: 27399066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of novel nomograms to predict renal functional outcomes after laparoscopic adrenalectomy in patients with primary aldosteronism.
    Utsumi T; Kamiya N; Kaga M; Endo T; Yano M; Kamijima S; Kawamura K; Imamoto T; Ichikawa T; Suzuki H
    World J Urol; 2017 Oct; 35(10):1577-1583. PubMed ID: 28401356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of kidney function with residual hypertension after treatment of aldosterone-producing adenoma.
    ; Wu VC; Chueh SC; Chang HW; Lin LY; Liu KL; Lin YH; Ho YL; Lin WC; Wang SM; Huang KH; Hung KY; Kao TW; Lin SL; Yen RF; Chen YM; Hsieh BS; Wu KD
    Am J Kidney Dis; 2009 Oct; 54(4):665-73. PubMed ID: 19628318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of postoperative renal function after adrenalectomy in patients with primary aldosteronism.
    Onohara T; Takagi T; Yoshida K; Iizuka J; Okumi M; Kondo T; Ishida H; Tanabe K
    Int J Urol; 2019 Feb; 26(2):229-233. PubMed ID: 30384394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal damage in primary aldosteronism: results of the PAPY Study.
    Rossi GP; Bernini G; Desideri G; Fabris B; Ferri C; Giacchetti G; Letizia C; Maccario M; Mannelli M; Matterello MJ; Montemurro D; Palumbo G; Rizzoni D; Rossi E; Pessina AC; Mantero F;
    Hypertension; 2006 Aug; 48(2):232-8. PubMed ID: 16801482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.